Financial News · Live Terminal

Page 36 of 519

Morgan Stanley Initiates Coverage on Revolution Medicines With Overweight Rating

Revolution Medicines (RVMD) has an average rating of buy and mean price target of $242.68, according to analysts polled by FactSet.

$RVMD

Research14d ago

Bernstein Initiates FedEx Freight at Market Perform With $133 Price Target

FedEx Freight Holding Company, Inc. (FDXF) has an average rating of overweight and mean price target of $168.31, according to analysts polled by FactSet.

$FDXF

Research14d ago

Evercore ISI Downgrades Chewy to In Line From Outperform, Cuts Price Target to $25 From $33

Chewy (CHWY) has an average rating of overweight and mean price target of $31.09, according to analysts polled by FactSet.

$CHWY

Research14d ago

Piper Sandler Downgrades Cooper to Neutral From Overweight, Raises Price Target to $59 From $86

Cooper (COO) has an average rating of overweight and mean price target of $70.62, according to analysts polled by FactSet.

$COO

Research14d ago

Bernstein Initiates XPO at Outperform With $244 Price Target

XPO (XPO) has an average rating of overweight and mean price target of $236.45, according to analysts polled by FactSet.

$XPO

Research14d ago

Bernstein Initiates Saia at Outperform With $439 Price Target

Saia (SAIA) has an average rating of overweight and mean price target of $438.43, according to analysts polled by FactSet.

$SAIA

Research14d ago

Bernstein Initiates Knight-Swift Transportation at Outperform With $91 Price Target

Knight-Swift Transportation Holdings (KNX) has an average rating of overweight and mean price target of $90.42, according to analysts polled by FactSet.

$KNX

Research14d ago

BMO Capital Downgrades Anglogold Ashanti to Market Perform From Outperform, $115 Price Target

Anglogold Ashanti (AU) has an average rating of overweight and mean price target of $135.59, according to analysts polled by FactSet.

$AU

Research14d ago

HSBC Downgrades Amgen to Hold From Buy, Adjusts Price Target to $425 From $445

Amgen (AMGN) has an average rating of hold and mean price target of $396.46, according to analysts polled by FactSet.

$AMGN

Research14d ago

Goldman Sachs Initiates Coverage on Abivax With Buy Rating, $155 Price Target

Abivax (ABVX) has an average rating of buy and mean price target of $162.06, according to analysts polled by FactSet.

$ABVX

Research14d ago

Huntington Capital Initiates Strawberry Fields REIT at Market Perform With $15 Price Target

Strawberry Fields REIT, Inc. (STRW) has an average rating of overweight and mean price target of $15.56, according to analysts polled by FactSet.

$STRW

Research14d ago

Deutsche Bank Initiates Clover Health Investments at Buy With $6 Price Target

$CLOV

Research14d ago

Roth Capital Initiates Coverage on Fatpipe With Buy Rating, $8 Price Target

Fatpipe, Inc. (FATN) has an average rating of Buy and mean price target of $10, according to analysts polled by FactSet.

$FATN

Research14d ago

Huntington Capital Initiates Chiron Real Estate at Market Perform With $37 Price Target

Chiron Real Estate Inc. (XRN) has an average rating of overweight and mean price target of $40.86, according to analysts polled by FactSet.

$XRN

Research14d ago

Huntington Initiates Sabra Health Care REIT at Outperform With $23 Price Target

Sabra Health Care REIT (SBRA) has an average rating of overweight and mean price target of $22.80, according to analysts polled by FactSet.

$SBRA

Research14d ago

Huntington Initiates National Health Investors at Outperform With $79 Price Target

National Health Investors (NHI) has an average rating of overweight and mean price target of $81.56, according to analysts polled by FactSet.

$NHI

Research14d ago

Huntington Initiates LTC Properties at Outperform With $47 Price Target

LTC Properties (LTC) has an average rating of overweight and mean price target of $45.25, according to analysts polled by FactSet.

$LTC

Research14d ago

Huntington Initiates Janus Living at Outperform With $36 Price Target

Janus Living (JAN) has an average rating of buy and mean price target of $34.46, according to analysts polled by FactSet.

$JAN

Research14d ago

Huntington Initiates CareTrust REIT at Outperform With $44 Price Target

CareTrust REIT (CTRE) has an average rating of buy and mean price target of $45.07, according to analysts polled by FactSet.

$CTRE

Research14d ago

Chardan Initiates Adagene at Buy With $9 Price Target

Adagene (ADAG) has an average rating of buy and mean price target of $10.49, according to analysts polled by FactSet.

$ADAG

Showing 701-720 of 10370